Form 8-K - Current report:
SEC Accession No. 0001641172-25-016064
Filing Date
2025-06-23
Accepted
2025-06-23 16:05:20
Documents
13
Period of Report
2025-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 58855
2 EX-10.1 ex10-1.htm EX-10.1 183564
  Complete submission text file 0001641172-25-016064.txt   449123

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mtnb-20250623.xsd EX-101.SCH 3038
4 XBRL LABEL FILE mtnb-20250623_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE mtnb-20250623_pre.xml EX-101.PRE 22374
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3716
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 251064967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)